109 related articles for article (PubMed ID: 1329226)
1. Phase I study of oral teniposide (VM-26).
Smit EF; Ousterhuis BE; Berendsen HH; Sleijfer DT; Postmus PE
Semin Oncol; 1992 Apr; 19(2 Suppl 6):35-9. PubMed ID: 1329226
[TBL] [Abstract][Full Text] [Related]
2. A phase I study of daily oral teniposide for 20 days.
Smit EF; Splinter TA; Kok TC
Semin Oncol; 1992 Apr; 19(2 Suppl 6):40-2. PubMed ID: 1411637
[TBL] [Abstract][Full Text] [Related]
3. The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.
Cascinu S; Del Ferro E; Ligi M; Graziano F; Catalano G
Am J Clin Oncol; 1997 Oct; 20(5):477-8. PubMed ID: 9345331
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of teniposide in adenocarcinoma of the lung.
Sørensen JB; Bach F; Dombernowsky P; Hansen HH
Cancer Chemother Pharmacol; 1991; 27(6):487-9. PubMed ID: 2013120
[TBL] [Abstract][Full Text] [Related]
5. Treatment of brain metastases of small cell lung cancer with teniposide.
Postmus PE; Smit EF; Berendsen HH; Sleijfer DT; Haaxma-Reiche H
Semin Oncol; 1992 Apr; 19(2 Suppl 6):89-94. PubMed ID: 1329230
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of teniposide in advanced breast cancer.
Boas J; Rasmussen D; Hansen OP; Engelholm SA; Dombernowsky P
Cancer Chemother Pharmacol; 1990; 25(6):463-4. PubMed ID: 2311176
[TBL] [Abstract][Full Text] [Related]
7. Teniposide in the treatment of non-small cell lung carcinoma.
Giaccone G; Donadio M; Ferrati P; Bonardi G; Ciuffreda L; Bagatella M; Calciati A
Cancer Treat Rep; 1987 Jan; 71(1):83-5. PubMed ID: 3024829
[TBL] [Abstract][Full Text] [Related]
8. Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Postmus PE; Smit EF; Haaxma-Reiche H; van Zandwijk N; Ardizzoni A; Quoix E; Kirkpatrick A; Sahmoud T; Giaccone G
J Clin Oncol; 1995 Mar; 13(3):660-5. PubMed ID: 7884426
[TBL] [Abstract][Full Text] [Related]
9. High-dose teniposide for refractory malignancies: a phase I study.
de Vries EG; Mulder NH; Postmus PE; Vriesendorp R; Willemse PH; Sleijfer DT
Cancer Treat Rep; 1986 May; 70(5):595-8. PubMed ID: 3708608
[TBL] [Abstract][Full Text] [Related]
10. Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
Bork E; Hansen M; Dombernowsky P; Hansen SW; Pedersen AG; Hansen HH
J Clin Oncol; 1986 Apr; 4(4):524-7. PubMed ID: 3007684
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin and teniposide chemotherapy for advanced non-small cell lung cancer.
Iberti V; Donadio M; Giaccone G
Eur J Cancer; 1991; 27(9):1104-6. PubMed ID: 1659849
[TBL] [Abstract][Full Text] [Related]
12. Treatment of extensive small cell lung cancer with carboplatin and teniposide.
Sørensen BT; Nielsen K; Steenholdt S; Schultz H; Jakobsen A
Eur J Cancer; 1991; 27(9):1109-12. PubMed ID: 1659851
[TBL] [Abstract][Full Text] [Related]
13. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
14. Absolute bioavailability and pharmacokinetics of oral teniposide.
Splinter TA; Holthuis JJ; Kok TC; Post MH
Semin Oncol; 1992 Apr; 19(2 Suppl 6):28-34. PubMed ID: 1411636
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
[TBL] [Abstract][Full Text] [Related]
16. Teniposide (VM-26) and carboplatin as initial therapy for small cell lung cancer.
Goss GD; Vincent M; Corringham R; Germond C; Sinoff C; Kane G; Rowen J; Corringham S; Dhaliwal H
Semin Oncol; 1992 Apr; 19(2 Suppl 6):69-74. PubMed ID: 1329228
[TBL] [Abstract][Full Text] [Related]
17. Teniposide in recurrent or advanced cervical carcinoma: a phase II trial in patients not previously treated with cytotoxic therapy.
Pfeiffer P; Cold S; Bertelsen K; Panduro J; Sandberg E; Rose C
Gynecol Oncol; 1990 May; 37(2):230-3. PubMed ID: 2344968
[TBL] [Abstract][Full Text] [Related]
18. The European Organization for Research and Treatment of Cancer experience with teniposide: preliminary results of a randomized study in non-small cell lung cancer.
Giaccone G; Splinter TA; Kirkpatrick A; Dalesio O; van Zandwijk N; McVie JG
Semin Oncol; 1992 Apr; 19(2 Suppl 6):98-102. PubMed ID: 1329231
[TBL] [Abstract][Full Text] [Related]
19. Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.
Grozea PN; Crowley JJ; Canfield VA; Kingsbury L; Ross SW; Beltran GS; Laufman LR; Weiss GR; Livingston RB
Cancer; 1997 Sep; 80(6):1029-33. PubMed ID: 9305702
[TBL] [Abstract][Full Text] [Related]
20. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
